Strikingly, all but 1 of these variants were predicted to activate Ras/Raf/MAPK signaling, providing strong evidence that they may contribute to MTLE risk, analogous to the role of somatic PI3K/Akt/mTOR variants in FCD. This evidence concerns the gene AKT1 and fleck corneal dystrophy.